Jonathan Laifer joins BelHealth as associate

Jonathan Laifer joined BelHealth Investment Partners as an associate. Laifer was previously an investment banking associate in the healthcare group at Goldman Sachs focusing on M&A, leveraged finance and equity transactions.

Press release

BelHealth Investment Partners (“BelHealth”), a healthcare-focused private equity firm, announced that Jonathan Laifer has joined the team as an Associate. Mr. Laifer’s responsibilities will range from deal origination to due diligence, execution and portfolio company monitoring.

Prior to joining BelHealth, Mr. Laifer was at Goldman Sachs, most recently as an Investment Banking Associate in the Healthcare group where he focused on M&A, leveraged finance and equity transactions. In addition, prior to attending business school, he worked as a financial analyst in Goldman’s Investment Management Division. He also completed an internship at Susquehanna Growth Equity.

Mr. Laifer received an M.B.A. from the Wharton School of the University of Pennsylvania where he graduated with honors and a B.B.A from Emory University.

Inder Tallur, Managing Director of BelHealth, said, “We are very excited to welcome Jon to BelHealth. He is a great addition to our growing team and worked with numerous leading healthcare companies while at Goldman. Jon will support our existing portfolio companies and is well prepared with a strong skill set to help analyze new investment opportunities.”

About BelHealth Investment Partners 

BelHealth Investment Partners, based in New York, New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes will benefit from its extensive operating and private equity investment expertise. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.